Skip to main content
Caplight Logo









OrganAID Holdings

OrganAID Holdings

Private
BarcelonaHealthcare & Life Scienceshttps://organaid.eu/

Last Round

Grant

Oct 17, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OrganAID Holdings is a biotechnology company that develops a drug-testing platform using brain organoids derived from patient cells and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

patient-derived organoidsorganoid drug screeningAI drug discoveryCRO servicesdrug toxicity testinganimal model alternativesbrain organoidspreclinical testingpersonalized medicinetissue avatarsorgan-on-a-chipdrug efficacy testingoncology drug discoveryneurology drug discoveryneurotoxicity testingiPSC organoids

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrganAID Holdings Comparables

Compare OrganAID Holdings with similar companies based on industry and business-model similarity.

OrganAID Holdings comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProxyBio
84%
Vivodyne
84%
CELLphenomics GmbH
79%

OrganAID Holdings Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 17, 2025

Key People

Founding team and executive leadership

Sandra Acosta

Chief Scientific Officer And Founder

Founding Team

OrganAID Holdings Investors

Notable investors and investment history

OrganAID Holdings investors
InvestorRounds
Pompeu Fabra UniversityGrant
University of BarcelonaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 17, 2025

    Received grant funding from "la Caixa" Foundation and universities.

OrganAID Holdings Filings

Explore SEC and related filing metadata, where available.

OrganAID Holdings filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OrganAID Holdings's valuation, stock price, and market status.

Is OrganAID Holdings a public or private company?

OrganAID Holdings is a private company.

What is the current stock price of OrganAID Holdings?

OrganAID Holdings is a private company with no public stock price. No recent secondary market data is available.

How much is OrganAID Holdings worth (valuation)?

Valuation information for OrganAID Holdings is not publicly available.

Can I buy OrganAID Holdings stock?

OrganAID Holdings shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OrganAID Holdings's last funding round?

Funding round information for OrganAID Holdings is not publicly available.

Who are the main investors in OrganAID Holdings?

Investor information for OrganAID Holdings is not publicly disclosed.

Will OrganAID Holdings IPO soon?

No public IPO plans have been announced for OrganAID Holdings.

How can I track OrganAID Holdings secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OrganAID Holdings's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBarcelona
Employee Range1
Year Founded2025
Last FundingOct 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?